S. Wang

发表

Cross-kingdom inhibition of breast cancer growth by plant miR159

Xiwei Wu, P. Swiderski, G. Somlo, 2016, Cell Research.

A mathematical model quantifies proliferation and motility effects of TGF-β on cancer cells.

Nicole S. Bryce, Alissa M. Weaver, G. Webb, 2007, Computational and mathematical methods in medicine.

Cell Cycle Arrest by Kaposi's Sarcoma-Associated Herpesvirus Replication-Associated Protein Is Mediated at both the Transcriptional and Posttranslational Levels by Binding to CCAAT/Enhancer-Binding Protein α and p21CIP-1

Frederick Y. Wu, M. Fujimuro, M. Lane, 2003, Journal of Virology.

Cell Cycle Arrest by Kaposi’s Sarcoma-Associated Herpesvirus Replication-Associated Protein Is Mediated at both the Transcriptional and Posttranslational Levels by Binding to CCAAT/Enhancer-Binding Protein and p21

Frederick Y. Wu, M. Fujimuro, M. Lane, 2003 .

CCAAT/Enhancer-Binding Protein- (cid:2) Is Induced during the Early Stages of Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) Lytic Cycle Reactivation and Together with the KSHV Replication and Transcription Activator (RTA) Cooperatively Stimulates the Viral RTA, MTA, and PAN Promoters

Frederick Y. Wu, G. Hayward, S. Wang, 2003 .

CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells.

W. Ye, P. Chu, Xiwei Wu, 2012, Cancer research.

Convergence of p53 and Transforming Growth Factor β (TGFβ) Signaling on Activating Expression of the Tumor Suppressor Gene maspin in Mammary Epithelial Cells*

Frederick Y. Wu, C. Arteaga, D. Friedman, 2007, Journal of Biological Chemistry.

Upregulated Expression of Indoleamine 2, 3-Dioxygenase in Primary Breast Cancer Correlates with Increase of Infiltrated Regulatory T Cells In Situ and Lymph Node Metastasis

S. Wang, Juntian Liu, Jing-yan Sun, 2011, Clinical & developmental immunology.

Transforming growth factor {beta} (TGF-{beta})-Smad target gene protein tyrosine phosphatase receptor type kappa is required for TGF-{beta} function.

Frederick Y. Wu, C. Arteaga, I. Shin, 2005, Molecular and cellular biology.

Trastuzumab has preferential activity against breast cancers driven by HER2 homodimers.

G. Mills, J. Balko, A. González-Angulo, 2011, Cancer research.

Extracellular Vesicles in Cancer Therapy.

S. Wang, Shizhen Emily Wang, 2022, Seminars in cancer biology.

Autologous cytokine-induced killer cell immunotherapy in lung cancer: a phase II clinical study

X. Hao, Chang-li Wang, S. Wang, 2012, Cancer Immunology, Immunotherapy.

Cytokines driving breast cancer stemness Molecular and Cellular Endocrinology

Andrew R. Chin, S. Wang, 2013 .

CCL2Mediates Crosstalk betweenCancer Cells and Stromal Fibroblasts That Regulates Breast Cancer Stem Cells

So, Xiwei Wu, Shiuan Chen, 2012 .

Cancer-cell-secreted Extracellular Vesicles Suppress Insulin Secretion through miR-122 to Impair Systemic Glucose Homeostasis and Contribute to Tumour Growth

Dorothy D. Sears, Wenwan Zhong, D. Pizzo, 2022, Nature Cell Biology.

Fibroblast-derived CCL2 induces cancer stem cells--response.

S. Wang, Shizhen Emily Wang, Akihiro Tsuyada, 2013, Cancer research.

Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis

David R. Jones, S. Rafii, C. Rudin, 2019, Nature Cell Biology.

HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors.

Carlos L Arteaga, Frederick Y. Wu, A. Gazdar, 2006, Cancer cell.

Reduction of cytosolic p27(Kip1) inhibits cancer cell motility, survival, and tumorigenicity.

Frederick Y. Wu, J. Baselga, F. Rojo, 2006, Cancer research.

Cancer-cell-secreted miR-122 suppresses O-GlcNAcylation to promote skeletal muscle proteolysis

J. Esko, D. Pizzo, Wei Yan, 2022, Nature cell biology.

Transforming Growth Factor (cid:2) Engages TACE and ErbB3 To Activate Phosphatidylinositol-3 Kinase/Akt in ErbB2-Overexpressing Breast Cancer and Desensitizes Cells to Trastuzumab (cid:1) †

J. Parker, C. Chung, A. Pandiella, 2022 .

Interferon- s: Special Immunomodulatory Agents and Potential Therapeutic Targets

S. Wang, Shizhen Emily Wang, Hui Li, 2013 .

CCAAT/Enhancer Binding Protein α Interacts with ZTA and Mediates ZTA-Induced p21CIP-1 Accumulation and G1 Cell Cycle Arrest during the Epstein-Barr Virus Lytic Cycle

Frederick Y. Wu, M. Fujimuro, G. Hayward, 2003, Journal of Virology.

Role of CCAAT/Enhancer-Binding Protein Alpha (C/EBPα) in Activation of the Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Lytic-Cycle Replication-Associated Protein (RAP) Promoter in Cooperation with the KSHV Replication and Transcription Activator (RTA) and RAP

Frederick Y. Wu, M. Fujimuro, G. Hayward, 2003, Journal of Virology.

Role of SOCS1 in tumor progression and therapeutic application

S. Wang, Hui Li, X. Ren, 2012, International journal of cancer.

TGF b Induces "BRCAness" and Sensitivity to PARP Inhibition in Breast Cancer by Regulating DNA-Repair Genes

Jeremy M. Stark, J. Stark, D. Ann, 2014 .

Multivariable Difference Gel Electrophoresis and Mass Spectrometry A CASE STUDY ON TRANSFORMING GROWTH FACTOR- (cid:1) AND ERBB2 SIGNALING* □ S

R. Caprioli, C. Arteaga, D. Friedman, 2006 .

A novel MDSC-induced PD-1−PD-L1+ B-cell subset in breast tumor microenvironment possesses immuno-suppressive properties

S. Wang, Shizhen Emily Wang, X. Ren, 2017, Oncoimmunology.

Anti-CD47 Antibody As a Targeted Therapeutic Agent for Human Lung Cancer and Cancer Stem Cells

Lin F. Yang, S. Wang, Shizhen Emily Wang, 2017, Front. Immunol..

MiR-205 in cancer: an angel or a devil?

S. Wang, Hui Li, X. Ren, 2013, European journal of cell biology.

Cytokines driving breast cancer stemness

Andrew R. Chin, S. Wang, 2014, Molecular and Cellular Endocrinology.

Transforming growth factor β regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM

Yang Yu, Xiwei Wu, S. Wang, 2010, Oncogene.

MicroRNA and HER2-overexpressing Cancer

R. Lin, S. Wang, Shizhen Emily Wang, 2013, MicroRNA.

H1047R phosphatidylinositol 3-kinase mutant enhances HER2-mediated transformation via heregulin production and activation of HER3

J. Engelman, C. Arteaga, R. Cook, 2010, Oncogene.

Therapeutics , Targets , and Chemical Biology Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER 2 Homodimers

G. Mills, J. Balko, C. Arteaga, 2011 .

Transforming Growth Factor (cid:2) Engages TACE and ErbB3 To Activate Phosphatidylinositol-3 Kinase/Akt in ErbB2-Overexpressing Breast Cancer and Desensitizes Cells to Trastuzumab (cid:1) †

Carlos L. Arteaga, Christine H. Chung, Joel Parker, 2008 .

Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins.

D. Yee, J. Engelman, C. Arteaga, 2008, The Journal of clinical investigation.

The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation.

G. Hayward, S. Wang, Y. Yu, 2005, Immunity.

Early Activation of the Kaposi's Sarcoma-Associated Herpesvirus RTA, RAP, and MTA Promoters by the Tetradecanoyl Phorbol Acetate-Induced AP1 Pathway

Frederick Y. Wu, G. Hayward, Q. Zheng, 2004, Journal of Virology.

Identification of a Cellular Protein That Interacts and Synergizes with the RTA (ORF50) Protein of Kaposi's Sarcoma-Associated Herpesvirus in Transcriptional Activation

Y. Geng, Shuhong Liu, S. Wang, 2001, Journal of Virology.

Breast cancer-secreted miR-122 reprograms glucose metabolism in pre-metastatic niche to promote metastasis

Weiying Zhou, Guoqiang Sun, Wenwan Zhong, 2015, Nature Cell Biology.

Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis.

Weiying Zhou, Yun Yen, Yang Yu, 2014, Cancer cell.

The Functional Crosstalk between HER2 Tyrosine Kinase and TGF-β Signaling in Breast Cancer Malignancy

S. Wang, Shizhen Emily Wang, 2011, Journal of signal transduction.

Oncogenic Mutations Regulate Tumor Microenvironment through Induction of Growth Factors and Angiogenic Mediators

C. Arteaga, L. Debusk, P. Lin, 2010, Oncogene.

UC Office of the President Recent Work Title De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer

Weiying Zhou, Yun Yen, John J Rossi, 2012 .

CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells.

W. Ye, P. Chu, Xiwei Wu, 2012, Cancer research.

Cancer Tills the Premetastatic Field: Mechanistic Basis and Clinical Implications

Andrew R. Chin, S. Wang, Shizhen Emily Wang, 2016, Clinical Cancer Research.

Inhibition of Transforming Growth Factor-β Signaling in Human Cancer: Targeting a Tumor Suppressor Network as a Therapeutic Strategy

C. Arteaga, T. Criswell, S. Wang, 2006, Clinical Cancer Research.

Overexpression of HER2 (erbB2) in Human Breast Epithelial Cells Unmasks Transforming Growth Factor β-induced Cell Motility*

C. Arteaga, N. Dumont, Y. Koh, 2004, Journal of Biological Chemistry.

Dual mechanisms of posttranscriptional regulation of Tet2 by Let-7 microRNA in macrophages

D. Baltimore, Shuai Jiang, Wei Yan, 2019, Proceedings of the National Academy of Sciences.

Cancer-cell-secreted miR-122 suppresses O-GlcNAcylation to promote skeletal muscle proteolysis

J. Esko, D. Pizzo, Wei Yan, 2022, Nature Cell Biology.

Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells

J. Locasale, D. Pizzo, Xiwei Wu, 2018, Nature Cell Biology.

Microenvironment and Immunology CCL 2 Mediates Crosstalk betweenCancer Cells and Stromal Fibroblasts That Regulates Breast Cancer Stem Cells

So, W. Ye, P. Chu, 2012 .

Polarized Secretion of Extracellular Vesicles by Mammary Epithelia

Wei Yan, Andrew R. Chin, S. Wang, 2018, Journal of Mammary Gland Biology and Neoplasia.

Let-7 Suppresses B Cell Activation through Restricting the Availability of Necessary Nutrients.

D. Baltimore, Shuai Jiang, Wei Yan, 2018, Cell metabolism.

Modeling the bidirectional glutamine/ammonium conversion between cancer cells and cancer-associated fibroblasts

P. Hinow, Wei Yan, S. Wang, 2021, PeerJ.

Chemotherapy Induces Breast Cancer Stemness in Association with Dysregulated Monocytosis

P. Chu, D. Pizzo, G. Somlo, 2018, Clinical Cancer Research.

Cell cycle arrest by Kaposi's sarcoma-associated herpesvirus replication-associated protein is mediated at both the transcriptional and posttranslational levels by binding to CCAAT/enhancer-binding protein alpha and p21(CIP-1).

Frederick Y. Wu, M. Fujimuro, M. Lane, 2003, Journal of virology.

Circulating miRNA profile in esophageal adenocarcinoma.

Jinhui Wang, Xiwei Wu, S. Wang, 2016, American journal of cancer research.

Tills the Premetastatic Field : Mechanistic Basis and Clinical Implications

Andrew R. Chin, S. Wang, Shizhen Emily Wang, 2016 .

TGFβ Induces “BRCAness” and Sensitivity to PARP Inhibition in Breast Cancer by Regulating DNA-Repair Genes

Weiying Zhou, Yang Yu, Hui Li, 2014, Molecular Cancer Research.

Extracellular Vesicles and Metastasis.

S. Wang, Shizhen Emily Wang, 2020, Cold Spring Harbor perspectives in medicine.

Nuclear Translocation of Type I Transforming Growth Factor β Receptor Confers a Novel Function in RNA Processing

R. Lin, A. Chow, J. Champer, 2012, Molecular and Cellular Biology.

Processing Confers a Novel Function in RNA Receptor β Transforming Growth Factor Nuclear Translocation of Type

Chow, Amy, R. Lin, 2012 .

Macrophage immunomodulation by breast cancer-derived exosomes requires Toll-like receptor 2-mediated activation of NF-κB

M. Kortylewski, A. Chow, Z. Meng, 2014, Scientific Reports.

HER2/Neu (ErbB2) signaling to Rac1-Pak1 is temporally and spatially modulated by transforming growth factor beta.

Frederick Y. Wu, C. Arteaga, I. Shin, 2006, Cancer research.

Chemotherapy-induced extracellular vesicle miRNAs promote breast cancer stemness by targeting ONECUT2.

D. Pizzo, Xiwei Wu, Wei Yan, 2019, Cancer research.

DNA Damage and Repair TGF b Induces " BRCAness " andSensitivity to PARP Inhibition in Breast Cancer by Regulating DNA-Repair Genes

Jeremy M. Stark, J. Stark, D. Ann, 2014 .

Gene targeting of ErbB3 using a Cre‐mediated unidirectional DNA inversion strategy

Hsiao-Huei Wu, C. Arteaga, M. Kotlikoff, 2006, Genesis.

Transforming Growth Factor (cid:2) (TGF- (cid:2) )-Smad Target Gene Protein Tyrosine Phosphatase Receptor Type Kappa Is Required for TGF- (cid:2) Function†

Frederick Y. Wu, C. Arteaga, I. Shin, 2022 .

A Single Extracellular Vesicle (EV) Flow Cytometry Approach to Reveal EV Heterogeneity.

Wenwan Zhong, Wei Yan, E. Wilson, 2018, Angewandte Chemie.

A Single Extracellular Vesicle (EV) Flow Cytometry Approach to Reveal EV Heterogeneity.

Wenwan Zhong, E. Wilson, Wei Yan, 2018, Angewandte Chemie.

Linking Changes in Epithelial Morphogenesis to Cancer Mutations Using Computational Modeling

Bahram Parvin, Hang Chang, Joe W. Gray, 2010, PLoS Comput. Biol..

Metastatic breast cancer cells overexpress and secrete miR-218 to regulate type I collagen deposition by osteoblasts

W. Chan, Xiwei Wu, A. Li, 2018, Breast Cancer Research.

The exploits of cancer's greedy sweet-tooth

M. Fong, S. Wang, 2015, Cell cycle.

Distribution profiling of circulating microRNAs in serum.

Wenwan Zhong, Xinping Cui, G. Somlo, 2014, Analytical chemistry.

Cancer-derived extracellular vesicles: the ‘soil conditioner’ in breast cancer metastasis?

Andrew R. Chin, S. Wang, Shizhen Emily Wang, 2016, Cancer and Metastasis Reviews.

Title Cancer-derived extracellular vesicles : the ' soil conditioner ' in breast cancer metastasis ?

Andrew R. Chin, S. Wang, Shizhen Emily Wang, 2016 .

A mathematical model of the disruption of glucose homeostasis in cancer patients

P. Hinow, S. Wang, Gabriella Pinter, 2023, bioRxiv.

Colocalization of Protein and microRNA Markers Reveals Unique Extracellular Vesicle Sub-Populations for Early Cancer Detection

Wenwan Zhong, Zongbo Li, Zuyang Ye, 2023, bioRxiv.

Cancer‐secreted miRNAs regulate amino‐acid‐induced mTORC1 signaling and fibroblast protein synthesis

Xiwei Wu, Xin Zhou, Jin Zhang, 2020, EMBO reports.

When Tumor Suppressor TGFβ Meets the HER2 (ERBB2) Oncogene

C. Arteaga, A. Chow, S. Wang, 2011, Journal of Mammary Gland Biology and Neoplasia.

UC Office of the President Recent Work Title Context-dependent bidirectional regulation of the mutS homolog 2 by transforming growth factor β contributes to chemoresistance in breast cancer cells

A. Li, S. Wang, Yang Yu, 2010 .

Transforming growth factor beta induces clustering of HER2 and integrins by activating Src-focal adhesion kinase and receptor association to the cytoskeleton.

A. Pozzi, V. Quaranta, C. Arteaga, 2009, Cancer research.

Calibration-free analysis of surface proteins on single extracellular vesicles enabled by DNA nanostructure.

Wenwan Zhong, Zongbo Li, Dong Yan, 2021, Biosensors & bioelectronics.

Multivariable Difference Gel Electrophoresis and Mass Spectrometry

R. Caprioli, C. Arteaga, D. Friedman, 2007, Molecular & Cellular Proteomics.

Cancer‐cell‐secreted extracellular vesicles target p53 to impair mitochondrial function in muscle

Wei Yan, S. Schenk, Y. Jones, 2023, EMBO reports.

A mathematical model separates quantitatively the cytostatic and cytotoxic effects of a HER2 tyrosine kinase inhibitor

Glenn F Webb, Peter Hinow, Carlos L Arteaga, 2007, Theoretical Biology and Medical Modelling.

Transforming Growth Factor Engages TACE and ErbB3 To Activate Phosphatidylinositol-3 Kinase/Akt in ErbB2-Overexpressing Breast Cancer and Desensitizes Cells to Trastuzumab †

J. Parker, C. Chung, A. Pandiella, 2008 .

Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells

J. Locasale, D. Pizzo, Xiwei Wu, 2018, Nature Cell Biology.

Interferon-λs: Special Immunomodulatory Agents and Potential Therapeutic Targets

S. Wang, Hui Li, X. Ren, 2012, Journal of Innate Immunity.

Receptor Association to the Cytoskeleton and Integrins by Activating Src-Focal Adhesion Kinase and Induces Clustering of HER 2 β Transforming Growth Factor

A. Pozzi, V. Quaranta, C. Arteaga, 2009 .

UC Office of the President Recent Work Title Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis

Hanlin Gao, Y. Yen, P. Chu, 2014 .

ERBB2 genetic polymorphism and breast cancer risk in Chinese women: a population-based case-control study

X. Shu, W. Zheng, W. Lu, 2008, Breast Cancer Research and Treatment.

Transforming Growth Factor (TGF- )-Smad Target Gene Protein Tyrosine Phosphatase Receptor Type Kappa Is Required for TGF- Function†

S. Wang, Frederick Y. Wu, Carlos L. Arteaga, 2005 .

CCAAT/Enhancer Binding Protein Binds to the Epstein-Barr Virus (EBV) ZTA Protein through Oligomeric Interactions and Contributes to Cooperative Transcriptional Activation of the ZTA Promoter through Direct Binding to the ZII and ZIIIB Motifs during Induction of the EBV Lytic Cycle

G. Hayward, S. Wang, S. Hayward, 2003 .

Transforming growth factor beta induces clustering of HER2 and integrins by activating Src-focal adhesion kinase and receptor association to the cytoskeleton.

A. Pozzi, V. Quaranta, C. Arteaga, 2009, Cancer research.

Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis.

M. Boldin, A. Li, G. Somlo, 2014, Cancer cell.

Cytokines driving breast cancer stemness

Andrew R. Chin, S. Wang, Shizhen Emily Wang, 2014, Molecular and Cellular Endocrinology.

De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer

Guihua Sun, Jinhui Wang, Yate-Ching Yuan, 2012, Journal of Translational Medicine.

Polarized Secretion of Extracellular Vesicles by Mammary Epithelia

Wei Yan, Andrew R. Chin, S. Wang, 2018, Journal of Mammary Gland Biology and Neoplasia.

Transforming growth factor beta induces clustering of HER2 and integrins by activating Src-focal adhesion kinase and receptor association to the cytoskeleton.

A. Pozzi, V. Quaranta, C. Arteaga, 2009, Cancer research.

Theoretical Biology and Medical Modelling Open Access a Mathematical Model Separates Quantitatively the Cytostatic and Cytotoxic Effects of a Her2 Tyrosine Kinase Inhibitor

G. Webb, P. Hinow, C. Arteaga, 2007 .